Previous close | 3.6400 |
Open | 3.5500 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 3.5500 - 3.6399 |
52-week range | 3.5500 - 39.6000 |
Volume | |
Avg. volume | 11,334 |
Market cap | 44.13M |
Beta (5Y monthly) | 0.49 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.3600 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
FORT MYERS, Fla., May 03, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (“AON” or the “Company”) (Nasdaq: AONC), a rapidly growing network of community-based oncology practices, announced today that Dave Gould will step down as Chief Financial Officer, effective May 17, 2024, to pursue other opportunities. AON has appointed David Afshar, a seasoned public company executive, to fulfill the responsibilities of interim Chief Financial Officer, effective May 20, 2024. AON has initiated a proces
FORT MYERS, Fla., April 30, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (“AON” or the “Company”) (Nasdaq: AONC), one of the fastest growing community-based oncology practices, announced today that the Company will release its first quarter 2024 financial results on Wednesday, May 15, 2024, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time on the same day. To access the call through a conference line, dial
The Foundation, a non-profit of the American Oncology Network, provides grants for essential non-medical expenses to cancer patients in need. American Oncology Cares Foundation Expands Non-Medical Financial Support to Local Cancer Patients in Indiana and Nevada From left to right: Shelly Glenn, AON's chief growth & relationship officer; Raja S. Mehdi, MD, medical oncologist at Hope Cancer Care of Nevada; Brian P. Mulherin, MD, medical oncologist at Hematology Oncology of Indiana; and Todd Schonh